# Dan Patrick Highlights THC in Texas Medical Cannabis Legislative Update > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/texas-medical-cannabis-legislative-update-thc-priorities/ > **Published:** 2026-03-27T15:04:49-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:36:40-04:00 > **Clinical Summary:** Stay informed on the Texas medical cannabis legislative update focusing on THC priorities and potential policy changes affecting patient access. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PolicyTexasAccess[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Thc Why This Matters Legislative priorities from influential state leaders like Texas Lt. Governor Dan Patrick can signal broader policy shifts that affect patient access to cannabis medicines. When THC appears alongside economic development priorities, it suggests potential movement toward evidence-based cannabis policy reform in traditionally restrictive states. Clinical Summary Texas Lt. Governor Dan Patrick has identified THC as one of his legislative priorities alongside data centers and prediction markets. This represents a notable development in a state with historically restrictive cannabis laws, where [medical cannabis access](https://cedclinic.com/medical-marijuana-card-reciprocity/) has been extremely limited through the Compassionate Use Program. The specific policy direction remains undefined, but inclusion in top-tier legislative priorities indicates potential regulatory changes that could affect patient access to THC-containing medications. Dr. Caplan’s Take “When conservative political leaders start mentioning THC in their priority lists, it usually means the clinical evidence and constituent pressure have reached a tipping point. Texas patients have been underserved by restrictive access policies for too long.” Clinical Perspective 🧠 Clinicians in Texas should monitor these legislative developments closely, as expanded access could significantly change treatment options for patients with qualifying conditions. This signals potential opportunity for evidence-based [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) to advance in a major restrictive state, though specific policy outcomes remain to be determined. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Dan%20Patrick%20adds%20data%20centers%2C%20prediction%20markets%20and%20THC%20to%20Senate%20priorities%20%40drcaplan&url=https%3A//www.newsfromthestates.com/article/dan-patrick-adds-data-centers-prediction-markets-and-thc-senate-priorities)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.newsfromthestates.com/article/dan-patrick-adds-data-centers-prediction-markets-and-thc-senate-priorities)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Dan%20Patrick%20adds%20data%20centers%2C%20prediction%20markets%20and%20THC%20to%20Senate%20priorities%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.newsfromthestates.com/article/dan-patrick-adds-data-centers-prediction-markets-and-thc-senate-priorities)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.newsfromthestates.com/article/dan-patrick-adds-data-centers-prediction-markets-and-thc-senate-priorities](https://www.newsfromthestates.com/article/dan-patrick-adds-data-centers-prediction-markets-and-thc-senate-priorities) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news) - [What type of cannabis policy is being discussed?](#What_type_of_cannabis_policy_is_being_discussed) - [Why is this news considered clinically relevant?](#Why_is_this_news_considered_clinically_relevant) - [What state is the focus of this medical cannabis news?](#What_state_is_the_focus_of_this_medical_cannabis_news) - [Who should pay attention to this cannabis policy news?](#Who_should_pay_attention_to_this_cannabis_policy_news) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely. #### What type of cannabis policy is being discussed? The article focuses on medical cannabis policy developments in Texas. It appears to cover access-related issues within the state’s medical cannabis program. #### Why is this news considered clinically relevant? The content addresses emerging findings or policy developments in medical cannabis that could impact patient care. Healthcare providers should stay informed about these changes as they may affect treatment options and patient access. #### What state is the focus of this medical cannabis news? Texas is the primary focus of this medical cannabis policy update. The article discusses developments specific to Texas’s medical cannabis access and regulations. #### Who should pay attention to this cannabis policy news? Healthcare professionals, particularly those involved in [medical cannabis treatment](https://cedclinic.com/medical-cannabis-eligibility-book-appointment/), should monitor these developments. Patients in Texas who use or are considering medical cannabis may also be affected by these policy changes. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Dan Patrick adds data centers, prediction markets and THC to Senate priorities”, “url”: “https://www.newsfromthestates.com/article/dan-patrick-adds-data-centers-prediction-markets-and-thc-senate-priorities”, “datePublished”: “2026-03-27T18:27:59Z”, “about”: “dan patrick adds data centers prediction”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Gov. Braun says reform possible on state's cannabis laws – WFYI](https://cedclinic.com/gov-braun-says-reform-possible-on-state-s-cannabis-laws-wfyi/) Explore insights on potential cannabis law reforms from Gov. Braun, highlighting evolving state policies that may influence patient access and clinical practice. [Read More](https://cedclinic.com/gov-braun-says-reform-possible-on-state-s-cannabis-laws-wfyi/) [New Clinical Insights on Cannabis and Patient Outcomes](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) Discover the latest clinical findings on cannabis and how they impact patient outcomes, providing valuable context for evolving cannabis policies. [Explore Insights](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) [Mississippi medical cannabis bills head to governor's desk – WLBT](https://cedclinic.com/mississippi-medical-cannabis-program-legislation/) Review recent legislative developments in Mississippi's medical cannabis program, offering a comparative perspective on state-level cannabis policy changes. [Learn More](https://cedclinic.com/mississippi-medical-cannabis-program-legislation/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).